* If you want to update the article please login/register
Terms Background The occurrence of thyrotoxicosis during pregnancy is mainly due to gestational transient thyrotoxicosis and Graves' disease. Since the two diseases are treated so differently, it is important to distinguish between GTT and Graves' disease. "Pregnancy" OR "pregnancy" OR "pregnancy") OR "pregnancy, (both fields) OR "pregnancy" OR "pregnancy] OR "pregnancy] ] OR "pregnancy" OR "pregnancy" OR "pregnancy]" OR "pregnancy" OR "pregnancy" OR "pregnancy" OR "pregnancy" OR "pregnancy" OR "pregnan" OR "pregnancy" OR /" OR " OR "pregnancy" OR " (pregnancy (pregna" OR ] (thyroid" OR "pregnancy (pregnancy" OR "pregnancy" OR "pregnancy"or thyroidism"pregna"pregnancy "pregnancy" OR "pregnancy (pregnancy"pregnancy"pregnancy) OR "pregnancy (pregnancy" PREGN"pregnancy"pre Ends Some clinical studies at home and abroad have suggested other important difference measurements, such as thyroid stimulating hormone, chorionic gonadotropin, thyroid hormone levels, and thyroid ultrasound. Conclusions These indicators are summarised here, with the intention of providing a more reliable benchmark for the differential diagnosis of hyperthyroidism during pregnancy in clinical practice.
Source link: https://europepmc.org/article/MED/36112207
One month after LT4's launch and prediction of P-CH in primary CH infants, the aim of this report is to determine the prevalence and causes for predicting iatrogenic hyperthyroidism. Methods This retrospective cohort study involved 87 infants with primary CH. According to 55. 6 and 21. 6 percent of patients, they were treated with initial doses of 10. 2 bcg/kg/day and 10. 2 bcg/day, respectively. An initial LT4 dose of 10. 2 u03bcg/kg/day was a safe cutoff value for predicting iatrogenic hyperthyroidism. After initial therapy, the only predictor of thyroid disease was the initial LT4 dose. Patients with P-CH were significantly higher in LT4 serum at 3 years of age, the only significant factor for predicting P-CH, was significantly higher in patients with P-CH. Conclusions Iatrogenic hyperthyroidism is common among infants with primary CH who are administered with the recommended LT4 dose. After LT4's introduction and diagnosis of P-CH, the only factor for predicting iatrogenic hyperthyroidism was the LT4 dose.
Source link: https://europepmc.org/article/MED/36100363
Background The severity of hyperthyroidism in Graves' disease has been shown to be acute in younger patients and slowly improves with age, as well as declining TSH receptor antibody levels. This research was conducted to see if decreasing TRAb production may be contributing to a decrease in severe hyperthyroidism among patients with GD. Patients newly diagnosed with GD at Ito Hospital between January 2005 and June 2019, were examined for medical records. Result A total of 21,018 patients with newly diagnosed GD were included in the study. Patients aged 40 years had a greater chance of severe hyperthyroidism in comparison to those aged 226740 years. The proportion of trab-related activity in determining the relationship between age and chronic hyperthyroidism was 8. 5% and 8. 4%, respectively, using fT4 and fT3 as an outcome measure.
Source link: https://europepmc.org/article/MED/36074931
Background: The effects of subthyroid dysfunction, particularly subthyroidism, on adverse pregnancy outcomes are inconclusive. Objective We hoped to investigate the effect of maternal SH on adverse maternal and neonatal outcomes based on urinary iodine concentrations. We used the results of 131 women with SH and 1650 cases of euthyroid disease in the United States. Preterm delivery was recorded in 12. 3% of women with SH and 6. 7% of those with euthyroid. Women with TSH 0. 3 mIU/L had a higher chance of preterm birth than those with TSHu2265 0. 3, despite urine iodine cut-off [OR= 2. 27; 95% CI: p = 0. 02]]. In Neonatal Intensive Care Unit admissions, no significant difference was found between these two study groups. This effect is more apparent in women with higher UIC than those with lower UIC.
Source link: https://europepmc.org/article/MED/36113393
Medline, PsycINFO, and Embase databases were searchable for systematic studies on the association of hyperthyroidism and clinical depression, without language or date constraints, until May 2020. In a DerSimonian-Laird random-effects meta-analysis, Odds ratios for the association of clinical depression and hyperthyroidism were calculated. Out of a total of 372 papers reviewed, we found 15 studies on 239 608 subjects, with 61% women and a mean age of 50, with 61% women and a mean age of 50. OR 1. 67, a result that was consistent in a variety of sensitivity and subgroup studies, with a higher risk of being diagnosed with clinical depression in relation to euthyroid patients and patients with hyperthyroidism. Chronic somatic disorders patients need medical attention and their reasons, including neurobiological pathways, common genetic abnormality, and a generally elevated risk of clinical depression in patients with chronic somatic disorders.
Source link: https://europepmc.org/article/MED/36064836
Despite patients with hyperthyroidism in current therapy who do not always have these signs, the commonly held association of hyperthyroidism with sinus tachycardia and widened pulse pressure has not been reassessed in decades. In the present day among people with different degrees of hyperthyroidism, the aim was to determine the prevalence and variability of sinus tachycardia and widened PP in the present day. Methods Data was obtained retrospectively from 248 adult patients in an outpatient setting with biochemical evidence of hyperthyroidism, measured heart rate, and blood pressure that were not controlled with drugs that could influence these values. The Median free thyroxine level reached 3. 49 ng/dL and thyroid stimulating hormone 0. 02 mIU/L. In this study, the relatively infrequent occurrence of tachycardia in comparison to older studies may indicate variations in the way medicine is practiced today. The increased ordering of thyroid function tests has most likely resulted in unmasked cases of mild or asymptomatic thyrotoxicosis.
Source link: https://europepmc.org/article/MED/36054093
Abstract Hyperthyroidism in the elderly population is often associated with atypical, dulled, or nonspecific signs and symptoms, as well as apathy hyperthyroidism. The vignette also features a diagnostic and therapeutic approach based on geriatric medicine fundamentals and evidence-based study. We then explore the multiple factors and pathogenetic mechanisms that contribute to endocrine disruptions and the paucity of hyperadrenergic signs and symptoms in elderly people with hyperthyroidism. To guide their clinical decision making, we recommend that nurse practitioners develop an illness script that includes atypical presentation.
Source link: https://europepmc.org/article/MED/36083321
Objectives: Graves' disease, a rare autoimmune disease in children, is the most common cause of hyperthyroidism. With the intention of finding new environmental causes, we set out to provide the first summary of temporal trends in pediatric hyperthyroidism in France and to investigate spatial trends. We conducted an observational population-based survey on data obtained from the National Health Data System, covering the 2008-2017 period and France as a whole. We discovered patients with an indicator that showed outbreak cases of treated hyperthyroidism in children aged 6 months to 17. 9 years, which was localized at the level of the du00e9partement of residence. Results We found 4734 incidents including 3787 girls and 947 boys. In the risk of childhood hyperthyroidism in France, the spatial model showed significant variability.
Source link: https://europepmc.org/article/MED/36074933
Graves' disease is the most common cause of hyperthyroidism in pediatric patients. Radiodine therapy is widely used to treat GD, but the predictors of RAIT's success in childhood and adolescence are also vague. 144 patients aged 8 to 18 years old who were eligible for primary dosimetry-guided RAIT for GD were included in the research. The initial thyroid measurement was the key predictor that made the biggest difference between the two groups of patients who achieved and did not achieve remission of GD hyperthyroidism after RAIT. The initial thyroid volume in 45. 4 ml was determined by using the Youden index at the ideal cut-off point. Conclusion: : The efficacy of the dosimetry-guided RAIT in pediatric patients with GD increased by 86% after 12 months, and one of the key predictors of RAIT success was a smaller thyroid volume.
Source link: https://europepmc.org/article/PPR/PPR539672
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions